Which Technology Changes Will Remain Important in 2021

Whether you’re an integrator, a designer or simply a label-defying creative, the EXPERIENCE is everything. Host Bryan Meszaros explores the story behind the exhibit to understand how a carefully crafted experience traps into the human experience to connect people to place.

 

If there has ever been a year where innovation has been most appreciated, it very well might be 2020. Almost everyone had to evolve and adapt in some way or another. Luckily for Bruce Barteldt, Chief Innovation Officer at Little Diversified Architectural Consulting, innovation isn’t out of his wheelhouse. An experienced design thinker and senior leader for over 30 years, as Chief Innovation Officer he aims to maximize the impact of Little’s diverse multi disciplined resources.

Bryan Meszaros, Host, Experience by Design spoke with Barteldt about how businesses have been challenged with finding new solutions and solving problems in 2020. “It’s a really great time to be a creative, because there’s so many problems that need so many solutions and sweeping ones at that. I don’t mean to be speaking to the tedious ones, I’m talking about massive culture change, massive changes to how we look out across the horizon of our lives,” Barteldt said.

Barteldt went on to explain how businesses adapt and change is similar to a pendulum swinging. “The way we culture business, kind of swings between classical forms of process and method,” Barteldt said. He continued to explain that he feels we aren’t in a period of necessarily brand new methods or brand new ways of creative problem solving, but he thinks there have been times in the past where there’s been a wake up call. “Some of it’s generational. Some of it’s the convergence of technologies and social change,” Barteldt said. In terms of how 2020 has forced change, “That’s been put in a pressure cooker due to the pandemic political clashing, this happened before. So the cycle back and forth, back and forth. I think we live in an age now because we have access to so much information, literally at our fingertips, that things shift back and forth rather swiftly,” Barteldt noted.

Join host Bryan Meszaros on Experience by Design every other Wednesday as he explores the latest trends and solutions helping craft the world’s most intriguing experiences.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More